Fig. 1 · Structure
Documents & Downloads
DTI 0009
A1 Receptor Agonist
DTI 0009 is a selective adenosine A1 receptor agonist that primarily targets the A1 receptor to modulate cardiovascular function. Its biological activity includes the reduction of heart rate, making it a potential therapeutic agent for treating atrial fibrillation and various arrhythmias. This compound serves as a valuable tool for research applications related to cardiac pharmacology and the mechanistic study of adenosine signaling pathways.
In Stock
Free Aliquoting for Your Order
Tell us your preferred amount per vial. We’ll confirm the options.
Specifications
| Manufacturer | Adooq Bioscience |
|---|---|
| Actions | Agonist |
| CAS Number | 110299-05-3 |
| Applications | A1 Receptor Agonist |
| Formula | C17H24N6O4 |
| Molecular Weight | 376.41 |
| Synonyms | GR 56072; RG 14202; Selodenoson |
| SMILES | O[C@H]1[C@@H](O)[C@H](N(C=N2)C3=C2C(NC4CCCC4)=NC=N3)O[C@@H]1C(NCC)=O |
Storage & Solubility
In Vitro Solubility
Reported Solubility
No reported solubility data are available for this product.
Preparing Stock Solutions
| Concentration | |
|---|---|
Values use four significant digits. Prepare to the final solution volume; this is not the volume of solvent to add.
Stock preparation is unavailable for this product molecular weight.
Calculated stock concentrations do not establish solvent solubility. Refer to the reported solubility data for experimental guidance.
Storage
Store powder at -20°C, keep desiccated.
In powder form, the chemical is stable for 36 months.
In solution, store at -20°C and use within 1 month to prevent loss of potency. Aliquot to avoid multiple freeze/thaw cycles.